Skip to main content

Tonix Pharmaceuticals Holding Corp.

TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001430306

In the last 90 days, Tonix Pharmaceuticals Holding Corp. insiders filed 2 open-market purchases and 0 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $119.4M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding Tonix Pharmaceuticals Holding Corp. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of TNXP: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders4024−16
Shares12.0M327.5K−11.7M (−97.3%)
Value$2.24M$227.1K−$2.01M (−89.9%)

New holders (6)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to TNXP in Q2 2024
InstitutionSharesValue% of portfolio
HRT Financial LP21,514$15.0K0.00%
UBS Group AG50$350.00%
BNP Paribas Arbitrage, SA10$70.00%
Twin Lakes Capital Management, LLC1$10.00%
Activest Wealth Management1$10.00%
Planning Capital Management Corp1$10.00%

Sold out (22)

Institutions that held Tonix Pharmaceuticals Holding Corp. at the end of Q1 2024 and filed for Q2 2024 without it.